Sue Fattor
Human Resources Officer chez FRESH TRACKS THERAPEUTICS, INC.
Profil
Sue Fattor is currently the Head of Human Resources at Fresh Tracks Therapeutics, Inc. She previously worked as the Director of Human Resources at Clovis Oncology, Inc. Ms. Fattor obtained an undergraduate degree and an MBA from The University of Colorado.
Postes actifs de Sue Fattor
| Sociétés | Poste | Début |
|---|---|---|
| FRESH TRACKS THERAPEUTICS, INC. | Human Resources Officer | - |
Anciens postes connus de Sue Fattor
| Sociétés | Poste | Fin |
|---|---|---|
| CLOVIS ONCOLOGY, INC. | Human Resources Officer | 10/07/2023 |
Formation de Sue Fattor
| The University of Colorado | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FRESH TRACKS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Clovis Oncology, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of innovative anti-cancer agents in the United States, Europe, and additional international markets. Its U.S. marketed product, Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP), is approved for use in the maintenance treatment and treatment of eligible adult patients with recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer, and also for the treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC), which have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy. In Europe, Rubraca is approved for use in recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. The company was founded by Andrew R. Allen, Gillian C. Ivers-Read, Patrick J. Mahaffy, and Erle T. Mast on April 20, 2009 and is headquartered in Boulder, CO. | Health Technology |
